Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03095248 |
| Title | Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors (SEL-TH-1601) |
| Acronym | SEL-TH-1601 |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Children's Hospital Medical Center, Cincinnati |
| Indications | |
| Therapies | |
| Age Groups: | child | adult |
| Covered Countries | USA |